cash position Archives - IRIS CAPITAL INVESTMENT

11 Jul 24

Theranexus – Implementation of a new equity line up to €2.5 Millions

Lyon, France, Jul 11, 2024 – Theranexus, a biopharmaceutical company innovating in the treatmentof rare neurological diseases, today publishes its cash position as of 30 June 2024, presents a progress report on Batten-1 and opens a new equity line. DOWNLOAD Theranexus press release Lyon, France – 11 juillet 2024, –…

11 Jul 24

Kalray – New financing secured up to €10 millions

Grenoble, France, Jul 11, 2024 – Kalray – KALRAY’S 2024 half revenue in line with latest announcements strong growth expected in the second half – New financing secured and confirmed outlook for expansion in AI data acceleration DOWNLOAD Kalray press release Kalray – Chiffre d’affaire semestriel conforme aux dernières annonces, forte…

14 Feb 24

New capital increase at Temisis with Société Financière Hoche Bains les Bains (SFHBB)

Vandoeuvre-lès-Nancy, France, Feb 14, 2024 – Groupe PAT – Nouvelle augmentation de capital chez Temisis avec la Société Financière Hoche Bains les Bains La Société Financière Hoche Bains les Bains , spécialisée dans la prise de participation et Plant Advanced Technologies PAT, entreprise pionnière dans la découverte et la production de…

13 Feb 24

Plant Advanced Technologies PAT is setting up an equity financing line of a maximum amount of 1 million euros with Iris.

Vandoeuvre-lès-Nancy, France, Feb 13, 2024 – Groupe PAT – Mise en place une ligne de financement en fonds propres auprès d’IRIS Plant Advanced Technologies PAT met en place une ligne de financement en fonds propres d’un montant maximum de 1 million d’euros auprès d’Iris. Groupe PAT – Establishment of an equity…

20 Nov 23

TheraVet announces the setting up of an equity-linked financing facility and updates on its financing strategy

Gosselies, Belgium, Nov 20, 2023 – TheraVet announces the setting up of an equity-linked financing facility and updates on its financing strategy DOWNLOAD THERAVET press release

13 Jul 23

THERANEXUS raises around 3.1 million euros in fundraising

Lyon, Jul 13, 2023 – THERANEXUS raises around 3.1 million euros in fundraising DOWNLOAD THERANEXUS press release

21 Jan 22

THERANEXUS Publishes its cash position as of 31 december 2021

Lyon, Jan 13, 2022 – THERANEXUS publishes its cash position as of 31 december 2021. Implementation of a new equity line. DOWNLOAD THERANEXUS press release

19 Jan 21

Theranexus implements a new equity line of an amount of up to €8.4 million in total over 12 months

Lyon, 18 January 2021 – Theranexus, a biopharmaceutical company innovating in the treatment of neurologicaldiseases and pioneer in the development of drug candidates modulating the interaction between neurons and glialcells, presents an update on its activities and announces the strengthening of its financial visibilityfor the medium term.

cash position

Links